{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:47:15Z","timestamp":1750160835372,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12883-018-1049-9","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T06:35:11Z","timestamp":1524465311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acquired modification of sphingosine-1-phosphate lyase activity is not related to adrenal insufficiency"],"prefix":"10.1186","volume":"18","author":[{"given":"Gulin","family":"Sunter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ece Oge","family":"Enver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azad","family":"Akbarzade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap","family":"Turan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Vatansever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilek Ince","family":"Gunal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goncagul","family":"Haklar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Bereket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadriye","family":"Agan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2658-6866","authenticated-orcid":false,"given":"Tulay","family":"Guran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"issue":"3","key":"1049_CR1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1172\/JCI90171","volume":"127","author":"R Prasad","year":"2017","unstructured":"Prasad R, Hadjidemetriou I, Maharaj A, Meimaridou E, Buonocore F, Saleem M, Hurcombe J, Bierzynska A, Barbagelata E, Bergad\u00e1 I, Cassinelli H, Das U, Krone R, Hacihamdioglu B, Sari E, Yesilkaya E, Storr HL, Clemente M, Fernandez-Cancio M, Camats N, Ram N, Achermann JC, Van Veldhoven PP, Guasti L, Braslavsky D, Guran T, Metherell LA. Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome. J Clin Invest. 2017;127(3):942\u201353.","journal-title":"J Clin Invest"},{"issue":"3","key":"1049_CR2","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1172\/JCI89626","volume":"127","author":"S Lovric","year":"2017","unstructured":"Lovric S, Goncalves S, Gee HY, Oskouian B, Srinivas H, Choi WI, Shril S, Ashraf S, Tan W, Rao J, Airik M, Schapiro D, Braun DA, Sadowski CE, Widmeier E, Jobst-Schwan T, Schmidt JM, Girik V, Capitani G, Suh JH, Lachauss\u00e9e N, Arrondel C, Patat J, Gribouval O, Furlano M, Boyer O, Schmitt A, Vuiblet V, Hashmi S, Wilcken R, Bernier FP, Innes AM, Parboosingh JS, Lamont RE, Midgley JP, Wright N, Majewski J, Zenker M, Schaefer F, Kuss N, Greil J, Giese T, Schwarz K, Catheline V, Schanze D, Franke I, Sznajer Y, Truant AS, Adams B, D\u00e9sir J, Biemann R, Pei Y, Ars E, Lloberas N, Madrid A, Dharnidharka VR, Connolly AM, Willing MC, Cooper MA, Lifton RP, Simons M, Riezman H, Antignac C, Saba JD, Hildebrandt F. Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency. J Clin Invest. 2017;127(3):912\u201328.","journal-title":"J Clin Invest"},{"issue":"4","key":"1049_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/humu.23192","volume":"38","author":"AR Janecke","year":"2017","unstructured":"Janecke AR, Xu R, Steichen-Gersdorf E, Waldegger S, Entenmann A, Giner T, Krainer I, Huber LA, Hess MW, Frishberg Y, Barash H, Tzur S, Schreyer-Shafir N, Sukenik-Halevy R, Zehavi T, Raas-Rothschild A, Mao C, M\u00fcller T. Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications. Hum Mutat. 2017;38(4):365\u201372.","journal-title":"Hum Mutat"},{"issue":"1","key":"1049_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/med.21402","volume":"37","author":"D Vogt","year":"2017","unstructured":"Vogt D, Stark H. Therapeutic strategies and pharmacological tools influencing S1P signaling and metabolism. Med Res Rev. 2017;37(1):3\u201351.","journal-title":"Med Res Rev"},{"issue":"11","key":"1049_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nrd3248","volume":"9","author":"V Brinkmann","year":"2010","unstructured":"Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, Aradhye S, Burtin P. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov. 2010;9(11):883\u201397.","journal-title":"Nat Rev Drug Discov"},{"issue":"40","key":"1049_CR6","doi-asserted-by":"publisher","first-page":"33697","DOI":"10.1074\/jbc.C500294200","volume":"280","author":"P Bandhuvula","year":"2005","unstructured":"Bandhuvula P, Tam YY, Oskouian B, Saba JD. The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity. J Biol Chem. 2005;280(40):33697\u2013700.","journal-title":"J Biol Chem"},{"issue":"8","key":"1049_CR7","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1002\/eji.201344158","volume":"44","author":"SM Park","year":"2014","unstructured":"Park SM, Angel CE, McIntosh JD, Brooks AE, Middleditch M, Chen CJ, Ruggiero K, Cebon J, Rod Dunbar P. Sphingosine-1-phosphate lyase is expressed by CD68+ cells on the parenchymal side of marginal reticular cells in human lymph nodes. Eur J Immunol. 2014;44(8):2425\u201336.","journal-title":"Eur J Immunol"},{"key":"1049_CR8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/B978-1-4377-0324-5.00015-8","volume-title":"Williams textbook of endocrinology","author":"PM Stewart","year":"2011","unstructured":"Stewart PM, Krone N. The adrenal cortex. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, editors. Williams textbook of endocrinology, vol. 1. 12th ed. Philadelphia: Saunders Elsevier; 2011. p. 479\u2013544.","edition":"12"},{"issue":"2","key":"1049_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00401-013-1140-7","volume":"126","author":"J Melief","year":"2013","unstructured":"Melief J, de Wit SJ, van Eden CG, Teunissen C, Hamann J, Uitdehaag BM, Swaab D, Huitinga I. HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter. Acta Neuropathol. 2013;126(2):237\u201349.","journal-title":"Acta Neuropathol"},{"key":"1049_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.bbi.2014.04.006","volume":"41","author":"S Kern","year":"2014","unstructured":"Kern S, Rohleder N, Eisenhofer G, Lange J, Ziemssen T. Time matters - acute stress response and glucocorticoid sensitivity in early multiple sclerosis. Brain Behav Immun. 2014;41:82\u20139.","journal-title":"Brain Behav Immun"},{"issue":"Pt 21","key":"1049_CR11","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1242\/jcs.111.21.3209","volume":"111","author":"T Goldkorn","year":"1998","unstructured":"Goldkorn T, Balaban N, Shannon M, Chea V, Matsukuma K, Gilchrist D, et al. H2O2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells. J Cell Sci. 1998;111(Pt 21):3209\u201320.","journal-title":"J Cell Sci"},{"issue":"18","key":"1049_CR12","doi-asserted-by":"publisher","first-page":"11313","DOI":"10.1074\/jbc.273.18.11313","volume":"273","author":"B Liu","year":"1998","unstructured":"Liu B, Andrieu-Abadie N, Levade T, Zhang P, Obeid LM, Hannun YA. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem. 1998;273(18):11313\u201320.","journal-title":"J Biol Chem"},{"issue":"1","key":"1049_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12883-017-0794-5","volume":"17","author":"T Saida","year":"2017","unstructured":"Saida T, Itoyama Y, Kikuchi S, Hao Q, Kurosawa T, Ueda K, Auberson LZ, Tsumiyama I, Nagato K, Kira JI. Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study. BMC Neurol. 2017;17(1):17.","journal-title":"BMC Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1049-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-018-1049-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1049-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T17:40:21Z","timestamp":1661017221000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-018-1049-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1049"],"URL":"https:\/\/doi.org\/10.1186\/s12883-018-1049-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"21 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Study was performed with the approval of the Ethics Committee of Marmara University, Faculty of Medicine, Istanbul, Turkey (09.2016.641). Patients provided written informed consent, and all studies were conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"48"}}